BNTC

Benitec Biopharma Inc.

7.53 USD
+0.06 (+0.80%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Benitec Biopharma Inc. stock is down -10.68% since 30 days ago. The next earnings date is Sep 19, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 22.22% of the previous 8 June’s closed higher than May. 100% of analysts rate it a buy.

About Benitec Biopharma Inc.

Benitec Biopharma focuses on the development of novel genetic medicines. The company is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. BB-103 for the treatment of chronic hepatitis B virus infection.